Thanks for the posts folks, much appreciated.
I was comparing the 1Q23 & 1Q24 Earnings-Presentationsbelow. I took note that a year earlier the company stated that they had changedover 144 million lives with their digital health products and cloud-basedsoftware solutions. Refer to the links below.
Revenue ($M) - Q1 FY23 - $950.3Non-GAAP Operating Income ($M) - Q1 FY23 - $290.8
Non-GAAP EPS - Q1 FY23 - $1.51
Fast forward a year to their 1Q24-Earnings-Presentationand the company have stated that they have now changed over 165 million liveswith their digital health products and cloud-based software solutions. That’san increase of 21 million lives in a period of a year.
Revenue ($M) - Q1 FY24 - $1,102.3
Non-GAAP Operating Income ($M) - Q1 FY24 - $318.8
Non-GAAP EPS - Q1 FY24 - $1.64
Take note that their goal is to transform 250million lives in a little over a year. That’s a hefty goal from here. They needto maintain existing clients (165 million) as strongly as they can and increasethose figures by approximately 84 million.As you can see it doesn’t mean that revenueincreases exponentially as result of client increase, but it does however creepup. The key from here is increasing the recurring revenue aspect of the businesswith continued good margins.
Q1 FY23 financial results
Devices - 55% - $1,866,908Masks and other - 34%
OOH SaaS - 11%
Q1 FY24 financial results
Devices - 51%Masks and other - 36%
OOH SaaS - 13%
Revenue by Region Q1 FY23
U.S., Canada, and Latin America - 61%Europe, Asia, and Other - 28%
OOH SaaS (U.S.) - 11%
Revenue by Region Q1 FY24
U.S., Canada, and Latin America - 58%Europe, Asia, and Other - 29%
OOH SaaS (U.S.) - 13%
Page 47 of the Annual Report below summarizes thecompany's net revenue disaggregated by segment, product and region for the yearended June 30, 2023 compared to the year ended June 30, 2022. Tony
https://s2.q4cdn.com/231003812/files/doc_downloads/2023/09/f9548081-3e6d-4ac3-8660-34f1ed7b3015.pdf
Tony
- Forums
- ASX - By Stock
- RMD
- Ann: ResMed Announces Results for the First Quarter of FY2024
Ann: ResMed Announces Results for the First Quarter of FY2024, page-46
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RMD (ASX) to my watchlist
|
|||||
Last
$29.90 |
Change
1.250(4.36%) |
Mkt cap ! $18.94B |
Open | High | Low | Value | Volume |
$29.38 | $29.90 | $29.28 | $56.93M | 1.920M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2798 | $29.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$29.91 | 9379 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 175 | 29.500 |
2 | 1174 | 29.390 |
1 | 1126 | 29.370 |
1 | 1000 | 29.300 |
1 | 1367 | 29.250 |
Price($) | Vol. | No. |
---|---|---|
29.970 | 750 | 1 |
29.980 | 2200 | 2 |
29.990 | 1400 | 4 |
30.000 | 11454 | 18 |
30.040 | 400 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
RMD (ASX) Chart |